In addition, inhibiting the expression of miR‐106b has been demonstrated to reduce the degree of joint inflammation and joint bone destruction in mice with rheumatoid arthritis by inhibiting synovial inflammation, regulating RANKL/OPG signalling and reducing the number of mature osteoclasts.19 The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.